2,033
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Technique failure in peritoneal dialysis-related peritonitis: risk factors and patient survival

, , , &
Article: 2205536 | Received 06 Jan 2023, Accepted 17 Apr 2023, Published online: 26 Apr 2023

References

  • Zeidan A, Bhandari S. Anemia in peritoneal dialysis patients; iron repletion, current and future therapies. Perit Dial Int. 2017;37(1):1–11.
  • Li PK-T, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153.
  • Mcdonald SCP, Hurst K, Jose M, et al. Peritoneal dialysis. ANZdata 2018 annual report. 2018.
  • Liu X, Qin A, Zhou H, et al. Novel predictors and risk score of treatment failure in peritoneal Dialysis-Related peritonitis. Front Med. 2021;8:639744.
  • He P, He LJ, Huang C, et al. Neutrophil-to-Lymphocyte ratio and treatment failure in peritoneal Dialysis-Associated peritonitis. Front Med. 2021;8:699502.
  • Tan YL, Ooi GS, Vaithilingam I. Factors predicting clinical outcomes of continuous ambulatory peritoneal dialysis associated peritonitis - A single Centre study. Med J Malaysia. 2021;76(3):382–389.
  • Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center. Ren Fail. 2021;43(1):993–1003.
  • Ma Y, Wang Y, Wang H-Y, et al. Predictors of short-term outcomes of patients with peritoneal dialysis-associated peritonitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018;40(1):13–20.
  • Al Sahlawi M, Zhao J, McCullough K, et al. Variation in peritoneal Dialysis-Related peritonitis outcomes in the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2022;79(1):45–55 e41.
  • Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–131.
  • Li PK-T, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423.
  • Li PK-T, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
  • Bonenkamp AA, van Eck van der Sluijs A, Dekker FW, et al. Technique failure in peritoneal dialysis: modifiable causes and patient-specific risk factors. Perit Dial Int. 2023;43(1):73–83.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Perl J, Davies SJ, Lambie M, et al. The peritoneal dialysis outcomes and practice patterns study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis. Perit Dial Int. 2016;36(3):297–307.
  • Perl J, Fuller DS, Bieber BA, et al. Peritoneal Dialysis-Related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53.
  • Hao N, Cheng B-C, Yang H-T, et al. Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study. BMC Nephrol. 2019;20(1):254.
  • See EJ, Johnson DW, Hawley CM, et al. Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand dialysis and transplant registry (ANZDATA) study. Am J Kidney Dis. 2018;72(2):188–197.
  • Kolesnyk I, Dekker FW, Boeschoten EW, et al. Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int. 2010;30(2):170–177.
  • Kim HJ, Lee J, Park M, et al. Lower education level is a risk factor for peritonitis and technique failure but not a risk for overall mortality in peritoneal dialysis under comprehensive training system. PLoS One. 2017;12(1):e0169063.
  • Sutherland TE, Shaw TN, Lennon R, et al. Ongoing exposure to peritoneal dialysis fluid alters resident peritoneal macrophage phenotype and activation propensity. Front Immunol. 2021;12:715209.
  • Nochaiwong S, Ruengorn C, Koyratkoson K, et al. A clinical risk prediction tool for Peritonitis-Associated treatment failure in peritoneal dialysis patients. Sci Rep. 2018;8(1):14797.
  • Li X, Wu J, Mao W. Evaluation of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus-related decompensated cirrhosis. J Clin Lab Anal. 2020;34(11):e23478.
  • Huang Y-J, Jiang Z-P, Zhou J-F, et al. Hypertriglyceridemia is a risk factor for treatment failure in patients with peritoneal dialysis-related peritonitis. Int Urol Nephrol. 2022;54(7):1583–1589.
  • Hommes JW, Kratofil RM, Wahlen S, et al. High density lipoproteins mediate in vivo protection against staphylococcal phenol-soluble modulins. Sci Rep. 2021;11(1):15357.
  • Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2016;12(1):37–47.
  • Ryu SY, Kleine C-E, Hsiung J-T, et al. Association of lactate dehydrogenase with mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2021;36(4):704–712.
  • Miyoshi N, Tanigawa T, Nishioka S, et al. Association of salivary lactate dehydrogenase level with systemic inflammation in a japanese population. J Periodontal Res. 2018;53(4):487–494.
  • Su Y, Ju M-J, Ma J-F, et al. Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study. Ann Transl Med. 2019;7(22):660.
  • Dias RCB, Vieira MA, Moro AC, et al. Characterization of Escherichia coli obtained from patients undergoing peritoneal dialysis and diagnosed with peritonitis in a Brazilian Centre. J Med Microbiol. 2019;68(9):1330–1340.
  • Htay H, Cho Y, Pascoe EM, et al. Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients. Perit Dial Int. 2020;40(1):47–56.
  • Zalunardo NY, Rose CL, Ma IW, et al. Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis. Kidney Int. 2007;71(7):687–692.
  • Yang C-Y, Chen T-W, Lin Y-P, et al. Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int. 2008;28(4):361–370.
  • Ye H, Lin X, Qiu Y, et al. Higher alkaline phosphatase was associated with the short-term adverse outcomes of peritoneal dialysis-related peritonitis. Clin Chem Lab Med. 2015;53(4):e113–116.
  • Campbell EL, MacManus CF, Kominsky DJ, et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci U S A. 2010;107(32):14298–14303.
  • Meng L, Yang L, Zhu X, et al. Development and validation of a prediction model for the cure of peritoneal Dialysis-Associated peritonitis: a multicenter observational study. Front Med (Lausanne). 2022;9:875154.
  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–1405.